Shawn M. Guertin - 28 May 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP & Chief Financial Officer
Signature: /s/ Shawn M. Guertin
Issuer symbol: CVS
Transactions as of: 28 May 2021
Net transactions value: +$11,433,246
Form type: 4
Filing time: 02 Jun 2021, 16:59:12 UTC
Previous filing: 18 May 2021
Next filing: 05 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock (restricted)	Award	$2,999,987	+34,706		$86.44	34,706	28 May 2021	Direct	F1
holding	CVS	Common Stock						9,260	28 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Award	$8,433,259	+97,562		$86.44	97,562	28 May 2021	Common Stock	97,562	$1.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse 5/28/2024.
F2	Option becomes exercisable in four equal annual installments, commencing 5/28/2022.